Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Blood Group Typing Market by Product (Instruments, Reagents & Kits) , by Test Type (ABO Tests, Antigen Typing, Antibody Screening, Cross-Matching Tests, HLA Typing) by Technique (Serology Tests, Molecular Tests) by End User (Hospital, Blood Banks) : Global Opportunity Analysis and Industry Forecast, 2024-2033

A02526

Pages: 280

Charts: 62

Tables: 162

Blood Group Typing Market Research, 2033

Market Introduction and Definition

The global blood group typing market size was valued at $2.0 billion in 2023, and is projected to reach $4.8 billion by 2033, growing at a CAGR of 9.4% from 2024 to 2033. Blood group typing is a crucial procedure in medicine that determines an individual's blood type based on the presence or absence of specific antigens and antibodies in their blood. The primary blood group systems are ABO system and Rh system. In the ABO system, blood is categorized into four main types, namely A, B, AB, and O. Type A blood has A antigens on the surface of red blood cells and anti-B antibodies in the plasma. Type B blood has B antigens and anti-A antibodies.  Type AB blood has both A and B antigens and does not have any anti-A or anti-B antibodies; and type O blood does not have any A or B antigens but has both anti-A and anti-B antibodies. The Rh system further classifies blood based on the presence (Rh-positive) or absence (Rh-negative) of the Rh factor, a protein found on the surface of red blood cells. The major factors driving the growth of the blood group typing market are increase in demand for accurate and efficient blood typing in medical diagnostics and transfusion medicine. In addition, advancements in technology, such as the development of automated and high-throughput blood typing systems, have improved accuracy and efficiency, further fueling the market growth. Rise in incidence of chronic diseases and the need for precise blood matching in personalized medicine are also significant drivers for the market growth. 

Key Takeaways 

  • The blood group typing market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major blood group typing industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
  • The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.

 Key Market Segments

  • By Product
    • Instruments
    • Reagents & Kits
  • By Test Type
    • ABO Tests
    • Antigen Typing
    • Antibody Screening
    • Cross-Matching Tests
    • HLA Typing
  • By Technique
    • Serology Tests
    • Molecular Tests
  • By End User
    • Hospital
    • Blood Banks
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA

 
Key Market Players

  • CareDx Inc.
  • Quotient Limited
  • Merck KGaA
  • Bio-Rad Laboratories, Inc. 
  • Illumina, Inc.
  • Immucor, Inc
  • Thermo Fisher Scientific Inc.
  • Agena Bioscience, Inc.
  • Diagast S.A.
  • Grifols, S.A.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: BLOOD GROUP TYPING MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Instruments

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Reagents And Kits

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: BLOOD GROUP TYPING MARKET, BY TEST TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Test Type

    • 5.2. ABO Tests

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Antigen Typing

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Antibody Screening

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Cross-Matching Tests

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. HLA Typing

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: BLOOD GROUP TYPING MARKET, BY TECHNIQUE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Technique

    • 6.2. Serology Tests

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Molecular Tests

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: BLOOD GROUP TYPING MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Hospital

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Blood Banks

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

  • CHAPTER 8: BLOOD GROUP TYPING MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Product

      • 8.2.3. Market Size and Forecast, By Test Type

      • 8.2.4. Market Size and Forecast, By Technique

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Blood Group Typing Market

        • 8.2.7.1. Market Size and Forecast, By Product
        • 8.2.7.2. Market Size and Forecast, By Test Type
        • 8.2.7.3. Market Size and Forecast, By Technique
        • 8.2.7.4. Market Size and Forecast, By End User

      • 8.2.8. Canada Blood Group Typing Market

        • 8.2.8.1. Market Size and Forecast, By Product
        • 8.2.8.2. Market Size and Forecast, By Test Type
        • 8.2.8.3. Market Size and Forecast, By Technique
        • 8.2.8.4. Market Size and Forecast, By End User

      • 8.2.9. Mexico Blood Group Typing Market

        • 8.2.9.1. Market Size and Forecast, By Product
        • 8.2.9.2. Market Size and Forecast, By Test Type
        • 8.2.9.3. Market Size and Forecast, By Technique
        • 8.2.9.4. Market Size and Forecast, By End User

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Product

      • 8.3.3. Market Size and Forecast, By Test Type

      • 8.3.4. Market Size and Forecast, By Technique

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Blood Group Typing Market

        • 8.3.7.1. Market Size and Forecast, By Product
        • 8.3.7.2. Market Size and Forecast, By Test Type
        • 8.3.7.3. Market Size and Forecast, By Technique
        • 8.3.7.4. Market Size and Forecast, By End User

      • 8.3.8. Germany Blood Group Typing Market

        • 8.3.8.1. Market Size and Forecast, By Product
        • 8.3.8.2. Market Size and Forecast, By Test Type
        • 8.3.8.3. Market Size and Forecast, By Technique
        • 8.3.8.4. Market Size and Forecast, By End User

      • 8.3.9. Italy Blood Group Typing Market

        • 8.3.9.1. Market Size and Forecast, By Product
        • 8.3.9.2. Market Size and Forecast, By Test Type
        • 8.3.9.3. Market Size and Forecast, By Technique
        • 8.3.9.4. Market Size and Forecast, By End User

      • 8.3.10. Spain Blood Group Typing Market

        • 8.3.10.1. Market Size and Forecast, By Product
        • 8.3.10.2. Market Size and Forecast, By Test Type
        • 8.3.10.3. Market Size and Forecast, By Technique
        • 8.3.10.4. Market Size and Forecast, By End User

      • 8.3.11. UK Blood Group Typing Market

        • 8.3.11.1. Market Size and Forecast, By Product
        • 8.3.11.2. Market Size and Forecast, By Test Type
        • 8.3.11.3. Market Size and Forecast, By Technique
        • 8.3.11.4. Market Size and Forecast, By End User

      • 8.3.12. Russia Blood Group Typing Market

        • 8.3.12.1. Market Size and Forecast, By Product
        • 8.3.12.2. Market Size and Forecast, By Test Type
        • 8.3.12.3. Market Size and Forecast, By Technique
        • 8.3.12.4. Market Size and Forecast, By End User

      • 8.3.13. Rest Of Europe Blood Group Typing Market

        • 8.3.13.1. Market Size and Forecast, By Product
        • 8.3.13.2. Market Size and Forecast, By Test Type
        • 8.3.13.3. Market Size and Forecast, By Technique
        • 8.3.13.4. Market Size and Forecast, By End User

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Product

      • 8.4.3. Market Size and Forecast, By Test Type

      • 8.4.4. Market Size and Forecast, By Technique

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Blood Group Typing Market

        • 8.4.7.1. Market Size and Forecast, By Product
        • 8.4.7.2. Market Size and Forecast, By Test Type
        • 8.4.7.3. Market Size and Forecast, By Technique
        • 8.4.7.4. Market Size and Forecast, By End User

      • 8.4.8. Japan Blood Group Typing Market

        • 8.4.8.1. Market Size and Forecast, By Product
        • 8.4.8.2. Market Size and Forecast, By Test Type
        • 8.4.8.3. Market Size and Forecast, By Technique
        • 8.4.8.4. Market Size and Forecast, By End User

      • 8.4.9. India Blood Group Typing Market

        • 8.4.9.1. Market Size and Forecast, By Product
        • 8.4.9.2. Market Size and Forecast, By Test Type
        • 8.4.9.3. Market Size and Forecast, By Technique
        • 8.4.9.4. Market Size and Forecast, By End User

      • 8.4.10. South Korea Blood Group Typing Market

        • 8.4.10.1. Market Size and Forecast, By Product
        • 8.4.10.2. Market Size and Forecast, By Test Type
        • 8.4.10.3. Market Size and Forecast, By Technique
        • 8.4.10.4. Market Size and Forecast, By End User

      • 8.4.11. Australia Blood Group Typing Market

        • 8.4.11.1. Market Size and Forecast, By Product
        • 8.4.11.2. Market Size and Forecast, By Test Type
        • 8.4.11.3. Market Size and Forecast, By Technique
        • 8.4.11.4. Market Size and Forecast, By End User

      • 8.4.12. Thailand Blood Group Typing Market

        • 8.4.12.1. Market Size and Forecast, By Product
        • 8.4.12.2. Market Size and Forecast, By Test Type
        • 8.4.12.3. Market Size and Forecast, By Technique
        • 8.4.12.4. Market Size and Forecast, By End User

      • 8.4.13. Malaysia Blood Group Typing Market

        • 8.4.13.1. Market Size and Forecast, By Product
        • 8.4.13.2. Market Size and Forecast, By Test Type
        • 8.4.13.3. Market Size and Forecast, By Technique
        • 8.4.13.4. Market Size and Forecast, By End User

      • 8.4.14. Indonesia Blood Group Typing Market

        • 8.4.14.1. Market Size and Forecast, By Product
        • 8.4.14.2. Market Size and Forecast, By Test Type
        • 8.4.14.3. Market Size and Forecast, By Technique
        • 8.4.14.4. Market Size and Forecast, By End User

      • 8.4.15. Rest of Asia Pacific Blood Group Typing Market

        • 8.4.15.1. Market Size and Forecast, By Product
        • 8.4.15.2. Market Size and Forecast, By Test Type
        • 8.4.15.3. Market Size and Forecast, By Technique
        • 8.4.15.4. Market Size and Forecast, By End User

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Product

      • 8.5.3. Market Size and Forecast, By Test Type

      • 8.5.4. Market Size and Forecast, By Technique

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Blood Group Typing Market

        • 8.5.7.1. Market Size and Forecast, By Product
        • 8.5.7.2. Market Size and Forecast, By Test Type
        • 8.5.7.3. Market Size and Forecast, By Technique
        • 8.5.7.4. Market Size and Forecast, By End User

      • 8.5.8. South Africa Blood Group Typing Market

        • 8.5.8.1. Market Size and Forecast, By Product
        • 8.5.8.2. Market Size and Forecast, By Test Type
        • 8.5.8.3. Market Size and Forecast, By Technique
        • 8.5.8.4. Market Size and Forecast, By End User

      • 8.5.9. Saudi Arabia Blood Group Typing Market

        • 8.5.9.1. Market Size and Forecast, By Product
        • 8.5.9.2. Market Size and Forecast, By Test Type
        • 8.5.9.3. Market Size and Forecast, By Technique
        • 8.5.9.4. Market Size and Forecast, By End User

      • 8.5.10. UAE Blood Group Typing Market

        • 8.5.10.1. Market Size and Forecast, By Product
        • 8.5.10.2. Market Size and Forecast, By Test Type
        • 8.5.10.3. Market Size and Forecast, By Technique
        • 8.5.10.4. Market Size and Forecast, By End User

      • 8.5.11. Argentina Blood Group Typing Market

        • 8.5.11.1. Market Size and Forecast, By Product
        • 8.5.11.2. Market Size and Forecast, By Test Type
        • 8.5.11.3. Market Size and Forecast, By Technique
        • 8.5.11.4. Market Size and Forecast, By End User

      • 8.5.12. Rest of LAMEA Blood Group Typing Market

        • 8.5.12.1. Market Size and Forecast, By Product
        • 8.5.12.2. Market Size and Forecast, By Test Type
        • 8.5.12.3. Market Size and Forecast, By Technique
        • 8.5.12.4. Market Size and Forecast, By End User

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning, 2024

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Quotient Limited

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. CareDx Inc.

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Agena Bioscience, Inc.

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Diagast S.A.

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Illumina, Inc.

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Grifols, S.A.

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Immucor, Inc

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Bio-Rad Laboratories, Inc. 

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Thermo Fisher Scientific Inc.

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Merck KGaA

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD GROUP TYPING MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL BLOOD GROUP TYPING MARKET FOR INSTRUMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL BLOOD GROUP TYPING MARKET FOR REAGENTS AND KITS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL BLOOD GROUP TYPING MARKET, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL BLOOD GROUP TYPING MARKET FOR ABO TESTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL BLOOD GROUP TYPING MARKET FOR ANTIGEN TYPING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL BLOOD GROUP TYPING MARKET FOR ANTIBODY SCREENING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL BLOOD GROUP TYPING MARKET FOR CROSS-MATCHING TESTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL BLOOD GROUP TYPING MARKET FOR HLA TYPING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL BLOOD GROUP TYPING MARKET, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL BLOOD GROUP TYPING MARKET FOR SEROLOGY TESTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL BLOOD GROUP TYPING MARKET FOR MOLECULAR TESTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL BLOOD GROUP TYPING MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL BLOOD GROUP TYPING MARKET FOR HOSPITAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL BLOOD GROUP TYPING MARKET FOR BLOOD BANKS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL BLOOD GROUP TYPING MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA BLOOD GROUP TYPING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 21. NORTH AMERICA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 22. U.S. BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 23. U.S. BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 24. U.S. BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 25. U.S. BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 26. CANADA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 27. CANADA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 28. CANADA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 29. CANADA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. MEXICO BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 31. MEXICO BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 32. MEXICO BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 33. MEXICO BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. EUROPE BLOOD GROUP TYPING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 35. EUROPE BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 36. EUROPE BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 37. EUROPE BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 38. EUROPE BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. FRANCE BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 40. FRANCE BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 41. FRANCE BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 42. FRANCE BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. GERMANY BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 44. GERMANY BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 45. GERMANY BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 46. GERMANY BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. ITALY BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 48. ITALY BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 49. ITALY BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 50. ITALY BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 51. SPAIN BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 52. SPAIN BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 53. SPAIN BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 54. SPAIN BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. UK BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 56. UK BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 57. UK BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 58. UK BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. RUSSIA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 60. RUSSIA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 61. RUSSIA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 62. RUSSIA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. REST OF EUROPE BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 64. REST OF EUROPE BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 65. REST OF EUROPE BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 66. REST OF EUROPE BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. ASIA-PACIFIC BLOOD GROUP TYPING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 68. ASIA-PACIFIC BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 69. ASIA-PACIFIC BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 70. ASIA-PACIFIC BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 71. ASIA-PACIFIC BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. CHINA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 73. CHINA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 74. CHINA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 75. CHINA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 76. JAPAN BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 77. JAPAN BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 78. JAPAN BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 79. JAPAN BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 80. INDIA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 81. INDIA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 82. INDIA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 83. INDIA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 84. SOUTH KOREA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 85. SOUTH KOREA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 86. SOUTH KOREA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 87. SOUTH KOREA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 88. AUSTRALIA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 89. AUSTRALIA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 90. AUSTRALIA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 91. AUSTRALIA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 92. THAILAND BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 93. THAILAND BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 94. THAILAND BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 95. THAILAND BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 96. MALAYSIA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 97. MALAYSIA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 98. MALAYSIA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 99. MALAYSIA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 100. INDONESIA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 101. INDONESIA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 102. INDONESIA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 103. INDONESIA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 104. REST OF ASIA PACIFIC BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 105. REST OF ASIA PACIFIC BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 106. REST OF ASIA PACIFIC BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 107. REST OF ASIA PACIFIC BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 108. LAMEA BLOOD GROUP TYPING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 109. LAMEA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 110. LAMEA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 111. LAMEA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 112. LAMEA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 113. BRAZIL BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 114. BRAZIL BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 115. BRAZIL BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 116. BRAZIL BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 117. SOUTH AFRICA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 118. SOUTH AFRICA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 119. SOUTH AFRICA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 120. SOUTH AFRICA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 121. SAUDI ARABIA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 122. SAUDI ARABIA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 123. SAUDI ARABIA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 124. SAUDI ARABIA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 125. UAE BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 126. UAE BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 127. UAE BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 128. UAE BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 129. ARGENTINA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 130. ARGENTINA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 131. ARGENTINA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 132. ARGENTINA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 133. REST OF LAMEA BLOOD GROUP TYPING, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 134. REST OF LAMEA BLOOD GROUP TYPING, BY TEST TYPE, 2025-2033 ($MILLION)
  • TABLE 135. REST OF LAMEA BLOOD GROUP TYPING, BY TECHNIQUE, 2025-2033 ($MILLION)
  • TABLE 136. REST OF LAMEA BLOOD GROUP TYPING, BY END USER, 2025-2033 ($MILLION)
  • TABLE 137. QUOTIENT LIMITED: KEY EXECUTIVES
  • TABLE 138. QUOTIENT LIMITED: COMPANY SNAPSHOT
  • TABLE 139. QUOTIENT LIMITED: OPERATING SEGMENTS
  • TABLE 140. QUOTIENT LIMITED: PRODUCT PORTFOLIO
  • TABLE 141. QUOTIENT LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. CAREDX INC.: KEY EXECUTIVES
  • TABLE 143. CAREDX INC.: COMPANY SNAPSHOT
  • TABLE 144. CAREDX INC.: OPERATING SEGMENTS
  • TABLE 145. CAREDX INC.: PRODUCT PORTFOLIO
  • TABLE 146. CAREDX INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. AGENA BIOSCIENCE, INC.: KEY EXECUTIVES
  • TABLE 148. AGENA BIOSCIENCE, INC.: COMPANY SNAPSHOT
  • TABLE 149. AGENA BIOSCIENCE, INC.: OPERATING SEGMENTS
  • TABLE 150. AGENA BIOSCIENCE, INC.: PRODUCT PORTFOLIO
  • TABLE 151. AGENA BIOSCIENCE, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. DIAGAST S.A.: KEY EXECUTIVES
  • TABLE 153. DIAGAST S.A.: COMPANY SNAPSHOT
  • TABLE 154. DIAGAST S.A.: OPERATING SEGMENTS
  • TABLE 155. DIAGAST S.A.: PRODUCT PORTFOLIO
  • TABLE 156. DIAGAST S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. ILLUMINA, INC.: KEY EXECUTIVES
  • TABLE 158. ILLUMINA, INC.: COMPANY SNAPSHOT
  • TABLE 159. ILLUMINA, INC.: OPERATING SEGMENTS
  • TABLE 160. ILLUMINA, INC.: PRODUCT PORTFOLIO
  • TABLE 161. ILLUMINA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 162. GRIFOLS, S.A.: KEY EXECUTIVES
  • TABLE 163. GRIFOLS, S.A.: COMPANY SNAPSHOT
  • TABLE 164. GRIFOLS, S.A.: OPERATING SEGMENTS
  • TABLE 165. GRIFOLS, S.A.: PRODUCT PORTFOLIO
  • TABLE 166. GRIFOLS, S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 167. IMMUCOR, INC: KEY EXECUTIVES
  • TABLE 168. IMMUCOR, INC: COMPANY SNAPSHOT
  • TABLE 169. IMMUCOR, INC: OPERATING SEGMENTS
  • TABLE 170. IMMUCOR, INC: PRODUCT PORTFOLIO
  • TABLE 171. IMMUCOR, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 172. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
  • TABLE 173. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
  • TABLE 174. BIO-RAD LABORATORIES, INC. : OPERATING SEGMENTS
  • TABLE 175. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
  • TABLE 176. BIO-RAD LABORATORIES, INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 177. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 178. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 179. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 180. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 181. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 182. MERCK KGAA: KEY EXECUTIVES
  • TABLE 183. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 184. MERCK KGAA: OPERATING SEGMENTS
  • TABLE 185. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 186. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD GROUP TYPING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL BLOOD GROUP TYPING MARKET
  • FIGURE 3. SEGMENTATION BLOOD GROUP TYPING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN BLOOD GROUP TYPING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBLOOD GROUP TYPING MARKET
  • FIGURE 11. BLOOD GROUP TYPING MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. BLOOD GROUP TYPING MARKET FOR INSTRUMENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. BLOOD GROUP TYPING MARKET FOR REAGENTS AND KITS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. BLOOD GROUP TYPING MARKET SEGMENTATION, BY BY TEST TYPE
  • FIGURE 15. BLOOD GROUP TYPING MARKET FOR ABO TESTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. BLOOD GROUP TYPING MARKET FOR ANTIGEN TYPING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. BLOOD GROUP TYPING MARKET FOR ANTIBODY SCREENING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. BLOOD GROUP TYPING MARKET FOR CROSS-MATCHING TESTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. BLOOD GROUP TYPING MARKET FOR HLA TYPING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. BLOOD GROUP TYPING MARKET SEGMENTATION, BY BY TECHNIQUE
  • FIGURE 21. BLOOD GROUP TYPING MARKET FOR SEROLOGY TESTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. BLOOD GROUP TYPING MARKET FOR MOLECULAR TESTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. BLOOD GROUP TYPING MARKET SEGMENTATION, BY BY END USER
  • FIGURE 24. BLOOD GROUP TYPING MARKET FOR HOSPITAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. BLOOD GROUP TYPING MARKET FOR BLOOD BANKS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: BLOOD GROUP TYPING MARKET
  • FIGURE 32. TOP PLAYER POSITIONING, 2024
  • FIGURE 33. QUOTIENT LIMITED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. QUOTIENT LIMITED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. QUOTIENT LIMITED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. CAREDX INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. CAREDX INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. CAREDX INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. AGENA BIOSCIENCE, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. AGENA BIOSCIENCE, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. AGENA BIOSCIENCE, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. DIAGAST S.A.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. DIAGAST S.A.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. DIAGAST S.A.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. ILLUMINA, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. ILLUMINA, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. ILLUMINA, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. GRIFOLS, S.A.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. GRIFOLS, S.A.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. GRIFOLS, S.A.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. IMMUCOR, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. IMMUCOR, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. IMMUCOR, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. BIO-RAD LABORATORIES, INC. : NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. BIO-RAD LABORATORIES, INC. : REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. BIO-RAD LABORATORIES, INC. : REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 60. MERCK KGAA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 61. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 62. MERCK KGAA: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Blood Group Typing Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved